A group of scientists based in the UK have developed an innovative 'lab-in-a-briefase' that is essentially an inexpensive and highly portable diagnostics tool. This contraption can be used to detect cancer bio-markers on the go, and takes as little as 15 minutes to offer accurate results.
This contraption uses a unique micro-fluid test strip to detect varies forms of cancer bio-markers by examining a blood sample, and works similar to a pregnancy tests. This system can test whole blood without the need to prepare samples.
Cancer detection is complicated even with the most advanced technology and the best doctors, but the problem is worsened in developing countries where high-tech diagnostic technology and equipment are often unavailable. The lab-in-a-briefcase tackles this by making it possible to carry out these tests on the go with minimal human resources and time.
Cancer-Diagnosing Briefcases
The Lab-In-A-Briefcase Assesses Cancer Bio-Markers In Only 15 Minutes
Trend Themes
1. Portable Cancer Diagnostics - The development of portable cancer diagnostic tools presents an opportunity for the healthcare industry to expand their reach in remote or low-resource regions.
2. Inexpensive Diagnostics - Developing low-cost diagnostic tools can make cancer screenings more accessible for patients and healthcare providers.
3. Microfluidics Technology - Incorporating microfluidics technology can transform the diagnostics industry by providing faster and more precise results.
Industry Implications
1. Healthcare - The healthcare industry can benefit from the development of portable and inexpensive cancer diagnostic tools that can expand their reach and improve patient care.
2. Technology - Technology companies can offer innovative solutions and products to diagnostic companies looking to incorporate microfluidics technology into their testing systems.
3. Pharmaceutical - Pharmaceutical companies can use these innovative diagnostic tools to improve their clinical trials and drug development processes by accurately assessing the efficacy of their products.